Advertisement
YOU ARE HERE: LAT HomeCollectionsFalse Advertising
IN THE NEWS

False Advertising

BUSINESS
February 23, 2006 | Claire Hoffman, Times Staff Writer
Netflix Inc. told a judge Wednesday that it would change the terms of a class-action settlement amid criticism that the online DVD rental company was going to use the accord to recruit customers. The settlement calls for Netflix to offer a month of free or upgraded service to more than 6 million current and former customers.
Advertisement
BUSINESS
December 16, 2005 | Myron Levin, Times Staff Writer
Philip Morris USA won a resounding legal victory Thursday when a divided Illinois Supreme Court overturned a $10.1-billion verdict over claims that the company deceptively marketed "light" cigarettes. In reversing the class-action award, the court did not absolve Philip Morris of the central allegation against it: that Philip Morris had consciously deterred smokers from quitting by falsely promoting "light," or low-tar, cigarettes as safer than regular brands.
HEALTH
November 14, 2005 | From Times wire reports
U.S. regulators said Thursday that they had issued warnings to companies that are promoting unproven "alternative" hormone therapies for women. The government sent letters to about 50 firms and websites that market supplements and creams as alternatives to hormone replacement therapy, warning them against making baseless claims that the treatments can help with serious diseases such as cancer, heart disease and osteoporosis.
HEALTH
November 14, 2005 | From Times wire reports
Producers of tomatoes, tomato sauce and dietary supplements containing lycopene -- the substance that makes tomatoes red -- will not be allowed to advertise claims that they reduce the risk of many forms of cancer, the Food and Drug Administration said Wednesday. But companies will be able to suggest a limited link between tomatoes and a lowered risk of prostate cancer, the agency said.
BUSINESS
October 19, 2005 | From Associated Press
A federal court has temporarily blocked marketers of an oral spray from making claims that the products contain growth hormones and can preserve youth, the government said. The Federal Trade Commission said that Pacific Herbal Sciences, Natural Health Product Inc. and New Star Marketing Group, all of California, have been barred from marketing HGH Revolution and Natural Rejuvenator HGH-R -- which don't actually contain human growth hormone, or HGH. The Oct.
BUSINESS
June 8, 2005 | Myron Levin, Times Staff Writer
Justice Department lawyers Tuesday asked a federal judge for sweeping sanctions against the biggest tobacco companies, saying the government had proved a 50-year industry conspiracy to mislead the public with "half truths, deceptions and lies that continue to this day." But without explanation, government attorneys drastically reduced their most expensive demand, scaling back a proposed industry-funded smoking-cessation program from $130 billion to $10 billion.
BUSINESS
June 3, 2005 | From Associated Press
Tropicana Products Inc. will stop claiming that its Healthy Heart orange juice will reduce the risk of heart disease and stroke, under a settlement reached with the Federal Trade Commission on Thursday. The FTC had alleged that Tropicana, a unit of PepsiCo Inc., misled consumers with claims that drinking two to three glasses a day of its Healthy Heart brand orange juice would produce dramatic effects on blood pressure and cholesterol.
BUSINESS
April 15, 2005 | From Bloomberg News
Sony BMG and Rosa Parks, who became a symbol for the U.S. civil rights movement when she refused to yield her seat on a segregated bus in 1955, settled her lawsuit over the use of her name in an OutKast song title, her lawyer said Thursday. The settlement included an agreement that a tribute CD featuring OutKast would be produced later this year by Sony BMG, the world's second-largest music company, to honor the 50th anniversary of Parks' arrest, her lawyer, Dennis Archer, said in a statement.
BUSINESS
March 15, 2005 | From Associated Press
Discount brokerage pioneer Charles Schwab Corp. sued the TD Waterhouse Group Inc. on Monday, alleging that its rival's advertisements falsely labeled Schwab as a high-priced firm with inferior service. The trade libel complaint filed in state court underscores Schwab's determination to reclaim its reputation as a bargain brokerage.
NATIONAL
March 12, 2005 | From Times Wire Reports
AstraZeneca has received its second warning in four months from the U.S. Food and Drug Administration over what the agency says are misleading claims in its ads for cholesterol-lowering medicine Crestor, the company said in New York. The latest letter said claims that Crestor lowers cholesterol better than Pfizer Inc.'s Lipitor were misleading because it cherry picked results from a study comparing the two medicines.
Los Angeles Times Articles
|